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ABSTRACT
Autonomical ly mediated non-pulmonary responses to various 
stimuli were studied in asthmatic and non-asthmatic individuals. 
In addition, the circadian changes in a number of autonomic and 
hormonal variables affecting airway calibre and their relation to 
circadian changes in peak expiratory flow rate were compared in 
similar groups of subjects.
I. THE PARASYMPATHETIC COMPONENT OP THE AUTONOMIC NERVOUS
SYSTEM:
This was studied by examining the heart rate variations 
induced by deep breathing (the magnitude of respiratory sinus 
arrhythmia), the Valsalva manoeuvre, and standing up from the 
recumbent position, all of which are parasympathetica1 ly 
mediated. The asthmatic patients had evidence suggesting enhanced 
parasympathetic neural output to the sino-atrial node, as 
manifested by a significantly greater magnitude of respiratory 
sinus arrhythmia than the normal control subjects. The heart rate 
responses to both the Valsalva manoeuvre and to standing up from 
the recumbent position were not, however, significantly different 
in asthmatic patients and normal subjects. No increase in the 
magnitude of respiratory sinus arrhythmia could be induced in 
normal subjects by breathing through an external resistance, 
suggesting that the finding was not a direct consequence of 
fluctuations in intrathoracic pressure related to airway obstruc­
tion. Non-asthmatic atopic subjects had a magnitude of
respiratory sinus arrhythmia which was intermediate between, but 
not significantly different from that of either the asthmatic 
patients or the normal control subjects.
A statistical analysis suggested the presence of a direct 
relationship between the magnitude of respiratory sinus 
arrhythmia and the degree of bronchial hyperreactivity in a group 
of asthmatic patients of varying severity. However, the 
suggestion of an enhancement of the parasympathetic neural 
output to the sino-atrial node in asthmatic patients could not be 
confirmed by a study of the "vagolytic" effect of atropine, which 
resulted in similar increments in the heart rates of both 
asthmatic and non-asthmatic subjects.
XI. THE ALPHA-ADRENERGIC COMPONENT OF THE SYMPATHETIC NERVOUS
SYSTEM:
As it was not possible to use a potent par enteral 1 y 
administered alpha-adrenergic agonist, the alpha-adrenergic 
component of the sympathetic nervous system was studied by 
examining the metabolic and cardiovascular responses to the 
alpha-2 agonist, clonidine. There was no difference in the 
responses of asthmatic and non-asthmatic individuals in the 
plasma growth hormone, glucose and potassium levels, or in the 
systolic and diastolic blood pressures following the adminis­
tration of a 150/ug oral dose. A number of the asthmatic 
patients, however, exhibited marked plasma growth hormone hyper­
responsiveness, and it was felt that they might possibly 
represent a subgroup of asthmatic patients in which alpha-
iv
adrenergic hypersensitivity was an important pathogenetic 
mechanism. For this reason, the patterns of growth hormone 
secretion in asthmatic patients were investigated further.
The responses to exercise in the plasma growth hormone and 
prolactin levels, both of which appear to be alpha-adrenergical ly 
mediated, as well as those in the levels of adrenocorticotropic 
hormone (ACTH) and cortisol were studied. The asthmatic patients 
were each studied twice; following the administration of anti­
asthmatic premedication which effectively prevented significant 
exercise— induced bronchospasm, and without premedication. The 
asthmatic patients appeared to have a diminished plasma cortisol 
response to exercise, although this was only statistically 
significant when exercise-induced bronchospasm was prevented by 
premedication. This finding did not appear to be explicable on 
the basis of corticosteroid therapy. There were no consistent 
differences in the other hormonal variables studied. Previous 
studies of the glucocorticoid response to exercise in asthmatic 
patients have yielded markedly conflicting results, and it is 
felt that confirmation of the present data is required before 
they can be considered in relation to the pathogenesis of asthma.
There was no difference between asthmatic and non-asthmatic 
subjects in the plasma growth hormone responses to exercise, and 
likewise, no significant difference in nocturnal growth hormone 
levels. A number of growth hormone "hyperresponders" and "hypo- 
responders" to the various stimuli studied appeared to be present 
among both the asthmatic and non-asthmatic subjects, and it is 
felt that the examination of growth hormone responses was not a
suitable method for the study of the alpha-adrenergic component 
of the autonomic nervous system.
III. THE BETA-ADRENERGIC COMPONENT OF THE SYMPATHETIC NERVOUS
SYSTEM:
This was studied by exa m i n i n g  the m e t a b o l i c  and 
cardiovascular responses of asthmatic and non-asthmatic subjects 
to the beta-2 agonist, salbutamol. The asthmatic patients had a 
significantly greater rj :e in plasma insulin levels than the 
normal control subjects following the intravenous administration 
of salbutamol. There were no consistent significant differences 
in the responses in the levels of plasma free fatty acids, 
glucose or potassium, the systolic and diastolic blood pressures, 
the pulse pressure or the heart rate.
No definite explanation can be given for the increased 
insulin response in the asthmatic patients, a surprising manifes­
tation in them of beta-adrenergic hypersensitivity. The present 
findings emphasise that autonomic events occurring in the 
respiratory tract are not necessarily a reflection of those 
occurring in other remote sites, as well as the need for caution 
in the interpretation of data obtained from the autonomic studies 
in asthma.
IV. THE CIRCADIAN CHANGES IN AUTONOMIC AND HORMONAL VARIABLES IN
RELATION TO CIRCADIAN CHANGES IN AIRWAY CALIBRE:
The m e c h a n i s m  of "morning dipping" in asthma was 
investigated by analysing circadian variations in sympathetic
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"activity" as reflected by the plasma epinephrine and 
norepinephrine levels, the parasympathetic "activity" as 
reflected by the heart rate and magnitude of respiratory sinus 
arrhythmia, the plasma levels of cortisol and ACTH, and the serum 
neutrophil chemotactic activity in asthmatic patients and normal 
subjects.
Plasma cortisol levels varied significantly during the study 
in all groups of subjects. The midnight plasma cortisol levels 
were significantly lower in the asthmatic patients with 
significant "dipping" than in either those without significant 
"dipping" or the normal subjects. The midnight plasma cortisol 
levels of the "non-dippers" were not significantly different from 
those of the normal subjects. The "dippers" exhibited greater 
circadian variations in the cortisol levels than either the "non­
dippers" or the normal subjects, whereas the magnitude of the 
circadian variations in the "non-dippers" resembled that of the 
normal subjects. There was a strong inverse correlation between 
the midnight plasma cortisol levels and the magnitude of the 
subsequent early morning fall in peak expiratory flow rate in the 
asthmatic patients.
There was no significant variation in the plasma epinephrine 
and norepinephrine level or in the serum neutrophil chemotactic 
activity during the study, nor any difference between the groups 
of subjects in any of these variables.
Although maximum, mean and minimum heart rate, and the 
magnitude of respiratory sinus arrhythmia exhibited a significant 
degree of variation during the study only in the asthmatics with
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"dipping", there was no difference between the groups of subjects 
in any of these variables. None of the electrocardiographic 
variables correlated, moreover, with the magnitude of the fall in 
the peak expiratory flow rate in the asthmatic subjects. The 
magnitude of respiratory sinus arrhythmia appeared to diminish in 
the patients with "dipping", despite the simultaneous occurrence 
of bronohoaonstriotion, suggesting that the latter was not
related to an increase in parasympathetic neural output.
Although the possibility could not be excluded that the 
lower midnight plasma cortisol levels observed in the asthmatic 
patients with "dipping" were related to therapy with 
bee 1omethasone dipropionate, thr finding in them of normal plasma 
levels of ACTH mitigated against a depressant effect of the 
compound on hypothalamic-pituitary-adrenal function. The present 
findings suggest that the relation of the plasma cortisol level 
to the bronchospasm which occurs under various clinical and 
experimental conditions requires elucidation. However, the effect 
of bedomethasone dipropionate on hypothalamic-pituitary-adrenal 
function in adults similarly requires further investigation.
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PREFACE
‘y
The airways of asthmatic patients characteristically exhibit 
hyperreactivity to diverse bronchoconstrictor stimuli. Although 
the precise cause of the phenomenon remains uncertain, a 
considerable amount of experimental evidence suggests that it may 
be related to some abnormality in the autonomic control of airway 
calibre which results in a predisposition to bronchoconstriction. 
As the possibility exists that any such abnormality could be part 
of a generalised autonomic derangement, the object of this thesis 
was to compare various aspects of autonomic nervous function in 
groups of asthmatic and non-asthmatic subjects. • review of the 
autonomic nervous innervation of the airways and ov the function 
nd regulation of autonomic receptors is followed by a 
description of the investigations performed. The descriptions of 
the investigations pertaining to a particular component of the 
autonomic nervous system are preceded in each case by a review of 
the existing experimental evidence, linking it to the 
pathogenesis of bronchial asthma.
The studies presented in this thesis were completed by 
March, 1986 and the reviews by December, 1986.
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SECTION I
INTRODUCTION
CHAPTER 1
THE PATHOGENESIS OF BRONCHIAL HYPERREACTIVITY IN ASTHMA
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The pulmonary airways of asthmatic patients character­
istically exhibit hyperreactivity ro numerous physical, chemical 
and pharmacological stimuli, the manifestation of which is the 
occurrence of reversible airway obstruction. The acuteness of 
onset of this response suggests that it is related mainly to 
smooth muscle contraction. The precise cause of airway 
hyperreactivity remains uncertain, despite being the subject of a 
considerable amount of research and speculation. A number of 
mechanisms, however, appear most likely to be responsible for the 
phenomenon (Boushey, 1980; Barnes, 1983). These are:
i. Diminished baseline airway calibre:
As t1- resistance to pulmonary airflow is inversely
related to the fourth power of the airway radius, further 
constriction of an abnormally narrow airway results in a
disproportionate increase in airway resistance when compared
with the response obtained in a normal airway. The 
demonstration, however, of airway hyperreactivity in 
patients without pre-existing airway obstruction, a 
relatively common finding in asthmatic patients in 
remission, suggests that decreased baseline airway calibre 
is a contributory, rather than an independent factor.
ii. Abnormality of the airway epithelium:
Acute viral infections of the respiratory tract have 
been shown to cause temporary airway hyperreactivity in non- 
asthmatic subjects, possibly as a result of damage to the 
epithelium, which allows Increased access to the underlying 
sensory receptors, or to the smooth muscle cells themselves,
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of various irritative stimuli. In a similar manner, a number 
of inflammatory mediators, including the different products 
of arachidonic acid metabolism and the various compounds 
associated with IgE-mediated hypersensitivity reactions, may 
be important in perpetuating a state of abnormally increased 
airway "permeability" in asthmatic patients.
Abnormality of airway smooth muscle:
Hypertrophy and hyperplasia of smooth muscle are known 
to occur in the airways of asthmatic patients. Whether these 
are primary abnormalities or the results of chronic smooth 
muscle contraction, they may contribute to airway 
hyperreactivity.
Abnormality of cellular calcium ion transport:
It has been suggested that patients with asthma may 
have a generalised increase in the transport of calcium ions 
across cell membranes. This could result in an enhancement 
in the contractility of smooth muscle as well as of mucus 
secretion and mast cell mediator release, each of which may 
be involved in the pathogenesis of asthma, and are, 
moreover, critically calcium ion dependent.
Disorders in the autonomic control of airway calibre:
That airway hyperreactivity in asthma may be related to 
some disorder in the autonomic control of airway calibre 
which predisposes to airway narrowing, has long been a 
popular hypothesis. The tone of airway smooth muscle is 
finely modulated by both the sympathetic and the 
parasympathetic components of the autonomic nervous system.
4
In addition, a non-adrenergic non-cholinergic (NANC) system 
which has recently been shown to be present in human airways 
appears to be important in the control of airway calibre. 
While both cholinergic and alpha-adrenergic agonists 
stimulate the contraction of airway smooth muscle, beta- 
adrenergic agonists cause it to relax. The NANC system may 
be involved in both inhibitory and contractile smooth muscle 
responses. Overactivity of any of the stimulatory 
components, or underactivity of any of the inhibitory 
components of this autonomic regulatory system could 
t h e o r e t i c a l l y  predispose to airway narrowing and 
hyperreactivity.
Autonomic mechanisms are al o closely involved in the 
control of the secretions of the airway glands and of the 
release of mediators from mast cells, abnormalities of both 
of which may be important in the pathogenesis of bronchial 
asthma.
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SECTION II
THE AUTONOMIC NERVE SUPPLY AND RECEPTORS OF THE RESPIRATORY TRACT
CHAPTER 2
PARASYMPATHETIC MECHAWTSmc
2.1 THE PARASYMPATHETIC INNERVATION OF THE RESPIRATORY TRACT
The parasympathetic responses occurring in the airways are 
m e diated by the local r elease of a c e t y l c h o l i n e  from 
parasympathetic nerve endings. The parasympathetic efferent nerve 
supply to the respiratory tract arises from the dorsal motor 
nucleus of the vagus in the floor of the fourth ventricle of the 
brain, and runs in the vagal trunks (Widdicombe and Sterling, 
1970). These preganglionic fibres synapse in ganglia located 
within the extrachondral and subchondral plexuses of the airway 
walls and in relation to the larger pulmonary blood vessels 
(Widdicombe, 1963; Spencer and Leof, 1964). The postganglionic 
fibres are distributed among the smooth muscle cells of the 
airways and a rich network of acetylcholinesterase-containing 
fibres is present from the central airways to the level of the 
terminal bronchioles (Partanen et a 1. 198 2; Sheppard MN et a 1.
1983) .
In the bovine trachea, postganglionic axons appear to be 
relatively sparse, with one axon occurring in relation to 
approximately ninety smooth muscle cells (Cameron and 
Kirkpatrick, 1977). The apparent lack of axons in direct 
proximity to muscle cells suggests the possibility that 
acetylcholine is released into the clefts between muscle bundles, 
resulting initially in the depolarisation of the more peripheral 
cells with subsequent excitation of the rest of the bundle 
(Cameron and Kirkpatrick, 1977). While axons appear to be 
similarly sparse in the human trachea, their density in the
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smaller bronchi is considerably greater - one axon being related 
to approximately three muscle cells (Daniel at a 1 . 1986). In 
addition to supplying the airway smooth muscle, parasympathetic 
fibres have been shown to terminate at the level of the mucous 
glands of the airways, where acetylcholinesterase-containing 
nerve fibres run around and between the bronchial glandular acini 
(Partanen at al. 1985).
Electrical stimulation of the vagpi trunks results in a 
rapid increase in the resistance to airflow, the response being 
typically cholinergic with inhibition by atropine, and 
enhancement by cholinesterase inhibitors (Colebatch and Halmagyi, 
1963; 01 sen at al. 1965). The reaction occurs within a second, 
reaching a maximum within six seconds, the control value being, 
likewise, rapidly regained after the cessation of stimulation 
(01 sen et al. 1965). This time-course suggests the relation of 
the response to smooth muscle contraction, rather than to an 
increase in glandular mucus secretion, and rapid freezing of the 
airway during vagal stimulation has demonstrated that this is, in 
fact, the case (01 sen et al. 1965). The contraction of smooth 
muscle in response to vagal stimulation has been shown to occur 
from the trachea to at least the level of the 0,5-lmm diameter 
bronchioles (Nadel et al. 1971).
Diverse stimuli originating in multiple sites in and remote 
from the airway result in reflex alterations in bronchomotor tone 
by modulating parasympathetic neural output. Thus:
i . Mechanics j. or chemical stimulation of the nose and
epipharynx produces a modest fall in airway resistance
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(Tomori and Widdicombe, 1969).
ii. Inflation of the lungs results in reflex relaxation of 
the trachea 1 muscle but large inflation volumes may also 
stimulate irritant receptors, resulting in the constriction 
of both lower and upper airway smooth muscle (Widdicombe,
1966) .
iii. A marked increase in total airway resistance results from 
the application of various physical and chemical irritative 
stimuli to the larj-nx, trachea and intrapulmonary airways 
(Nadel and Widdicombe, 1962; Nadel and Widdicombe, 1963? 
Nadel et a 1. 19 6 5? Tomori and Widdicombe, 1969? Boushey et 
al. 1972).
iv. Trachea 1 smooth muscle tone exhibits a small but 
significant inverse relationship to arterial pressure, 
which is mediated by reflexes involving carotid sinus 
baroreceptors (Nadel and Widdicombe, 19 62).
v. Arterial hypoxaemia and hypercapnia increase both lower 
and upper airway resistance by an effect on the carotid 
body chemoreceptors (Nadel and Widdicombe, 196 2).
The s.ensory fibres involved in those reflexes which 
originate in the airway appear to lie mainly within the vagal 
trunks (Sant'Ambrogio, 1982). Some afferent activity has been 
recorded in the sympathetic nerves of dogs, however, (Kostreva et 
al. 1975). These fibres may be parti y involved in the mediation 
of the rapid, shallow respiration that is produced by irritant 
substances such as bradykinin (Coleridge et al. 1.33). The 
sensory receptors involved are probably closely related to the
intra-epithelial nervea which have been shown to be present in 
sites both adjacent to the lumen and to the basement membrane of 
the larger airways in humans (Laitinen, 1985).
A number of functionally different receptors appear to be 
present in the airways. These are: (i) the "rapidly-adapting
irritant receptors with myelinated afferent fibres", (ii) the "C~ 
fibre receptors associated with non-myelinated afferent fibres", 
(iii) the "slowly-adapting receptors" (Widdicombe, 19^5). The 
latter are associated with the Hering-Breuer inflation reflex, 
and with the reflex bronchodilatation and cardiac acceleration 
produced by airway distension, and do not seem to be stimulated 
by pathological processes in the respiratory tract. By contrast 
the "vapidly-adapting receptors" are strongly stimulated by a 
variety of pathological, mechanical chemical processes. The
"C-fibre receptors" appear to be similarly "polymodal" being, 
however, somewhat less sensitive to mechanical stimuli 
(Widdicombe, 1985). Like the response associated with electrical 
vagal stimulation, the time-course of the reflex increase in 
airway resistance produced by irritative stimuli is rapid (Nadel 
et al. 1965; Tomor-i and Widdicombe, 1969), suggesting that it is 
due to smooth muscle contraction.
In the absence of any stimuli, there is normally a degree of 
resting airway smooth muscle tone, which has been shown in 
animals to be related to tonic parasympathetic activity (Nadel 
and Widdicombe, 1963; Widdicombe, 1966). The increase in airway 
calibre that occurs in normal human subjects following the 
administration of cholinergic antagonists (Nadel and Widdicombe,
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1963; De Troyer et al. 1979) confirms that this situation applies 
as well in man, the effect being mainly due to dilatation of the 
larger more central airways (Ingram et al. 1977; Hens ley et al.
1978) .
In addition to its modulatory effect on smooth muscle tone, 
the parasympathetic nervous system regulates the output of the 
secretions of the mucous glands of the airway epithelium. 
Different irritative stimuli applied to the nose, pharynx, larynx 
and lower airway produce a reflex increase in the output of mucus 
from the tracheobronchial glands (Phipps and Richardson, 1976; 
German et al. 1980), and this response is inhibited by atropine 
a::d by cooling of the vagal trunks (German et al. 1980). The 
sensory receptors for these reflexes also appear to be the 
"rapidly-adapting" and "C-fibre recepto.s" (Widdicombe, 1985), 
and the efferent fibres to lie within the vagal trunks. In vitro 
and in vivo electrical and pharmacological studies in a number of 
mammalian species, including man, have confirmed that cholinergic 
mechanisms are at least partly involved (Davis et al. 1976; 
Shelhamer et al. 19 8 0a; Borson et al. 19 8 0; Borson et al. 1984; 
Leikauf et al. 19 8 4) . In addition, it has been shown that 
acetylcholine stimulates the movement of sodium and chloride ions 
into the lumen of the human airway in vitro (Knowles et al.
1984).
2.2 MUSCARINIC RECEPTORS
There is ample evidence of the existence of muscarinic
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receptors in the mammalian respiratory tract. Studies using the 
radioligand (3H)quinuclidinyl benzilate have demonstrated their 
presence in the canine trachea (Murlas et al. 1982) as well as in 
bovine trachea and peripheral lung (Cheng and Townley, 1982). The 
density of the receptors appears to be considerably greater in 
the upper airway than in peripheral lung, and the contractile 
responses of the preparations to methacholine correlate with 
receptor density (Cheng and Townley, 1982). There also appears to 
be a correlation between the ability of different muscarinic 
agonists to inhibit the binding of the radioligand to canine 
tracheal membranes, and their relative contractile potency 
(Murlas et al. 1982). Radioligand binding to muscarinic receptors 
has also been demonstrated in fresh human lung obtained from 
surgical specimens (Raaijmakers et al. 1983).
Recent light microscopic autoradiographic studies have given 
an indication of the differential distribution of muscarinic 
receptors among the numerous cell types of the mammalian 
respiratory tract. The density of muscarinic receptors in the 
respiratory tract of the ferret is greatest in the smooth muscle 
of the trachea and the intrapulmonary cartilaginous airways and 
in the submucosal glands, and considerably less in bronchiolar 
smooth muscle, airway epithelium and vascular smooth muscle. 
There appear to be no receptors in the alveoli (Barnes et al. 
1983a; Barnes et al. 1983c).
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CHAPTER 3
SYMPATHETIC MECHANISMS
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3.1 the sy m p a t h e t i c i nn erva tion of the re s p i r a t o r y tra ct
The sympathetic nerve supply to the mammalian respiratory 
tract is generally less profuse than the parasympathetic supply 
but is characterised by a considerable variation between 
different species (Doidge and Satchel 1, 1982). As with the lower 
primates (E1-Bermani, 1978), the adrenergic innervation of the 
airways and lungs of humans appears to be sparse (Doidge and
Satchel 1, 1982).
The sympathetic outflow to the lungs arises from the unper
four or five thoracic segments of the spinal cord (Widdicombe .*..d 
Sterling, 1970). In contrast to parasympathetic fibres, 
sympathetic fibres tend to synapse in ganglia distant from the 
organ being innervated. In the case of the pulmonary sympathetic 
nerves, the preganglionic fibres relay mainly in the stellate and 
mid-cervical ganglia, from which postganglionic fibres pass to 
the lungs, mingling with the parasympathetic nerves, and forming 
part of the extra- and subchondral nerve plexuses of the airway 
(Mann, 1971) before undergoing distal distribution.
In humans as well as other mammals, postganglionic 
sympathetic fibres terminate in ganglia located within the airway 
wall (Richardson, 1979; Doidge and Satchel 1, 1982). While there
is definite evidence in a number of mammalian species of direct 
postganglionic sympathetic nervous innervation of both airway 
wall glands and smooth muscle, some workers have been unable to 
demonstrate catecholamine-containing nerves in human bronchi or 
lungs despite these being readily demonstrable in control
sections of guinea-pig trachea (Richardson £ d Beland, 1°76). 
This has led to the suggestion that no sim. ar nerve supp.y 
exists in man (Richardson, 1979), and that the pulmonary 
sympathetic nerve supply is primarily involved with vascular 
structures (Widdicombe and Sterling, 1970? Doidge and Satchel 1, 
1982? Widdicombe, 1985). However, both histochemical and electron 
microscopic studies have confirmed the presence of catecholamine- 
containing nerves in the human airway. They appear to be most 
abundant in relation to the bronchial glands where their amount 
and distribution is similar to that of the cholinergic fibres 
(Rartanen et al. 1982), and are, in addition, present in relation 
to both blood vessels and airway smooth muscle (Partanen et al. 
1982? Pack and Richardson, 1984? Laitinen A et al. 1985a). In 
addition, the presence of adrenergic fibres has been demonstrated 
by means of catecholamine antibodies in the upper respiratory 
tracts of various mammalian species, including man, where they 
are related to both smooth muscle and blood vessels, and to a 
lesser extent in the lungs, in relation to the vasculatvxe
(Sheppard MN et al. 1983).
The neurotransmitter of the sympathetic nervous system is 
norepinehprine, a potent alpha-adrenergic, but weak beta- 
adrenergic agonist, with no bronchodilator action in vivo in man 
(Berkin et al. 1986? Larsson et al. 1986). Although electrical 
field stimulation of in vitro preparations of canine bronchi 
results in the release of norepinephrine (Vermeire and Vanhoutte,
1979), studies of the effects of sympathetic nerve stimulation on 
airway smooth muscle tone in different mammalian species have
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given markedly conflicting results, probably related to inter­
species differences.
In an early study using an isolated guinea-pig trachea 1 
preparation in which the parasympathetic response had been 
abolished by atropine, transmural electrical stimulation resulted 
in smooth muscle relaxation, the effect being blocked by a beta- 
adrenergic antagonist, suggesting its mediation by postganglionic 
catecholamine release (Foster, 1964). In addition, electrical 
sympathetic nerve stimulation in both cats and dogs was shown to 
diminish the increase in airway resistance resulting from 
simultaneous vagal stimulation (Olsen et al. 1965). In a later 
study in dogs, supramaximal electrical sympathetic stimulation 
produced borne inhibition of vagal ly induced bronchoconstriction 
(Gabezas et al. 1971), but after vagotomy similar stimulation of 
the sympathetic trunks appeared to have no effect on airway 
smooth muscle tone (Gabezas et al. 1971). While an inhibitory 
response was produced in isolated strips of guinea pig tracheal 
muscle by electrical field stimulation in the presence of 
atropine, this was unaffected by either propranolol or practolol 
(Coburn and Tomita, 1973). Other workers, however, elicited a 
similar response in the isolated guinea-pig trachea to which 
there did appear to be an adrenergic component (Richardson and 
Bouchard, 1975). Likewise, stimulation of the sympathetic trunks 
in intact guinea-pigs appeared to elicit an adrenergic inhibitory 
response of the airway smooth muscle, which was clearly 
attenuated by propranolol (Chesrown et al. 1.980). However, two in 
vitro studies of human respiratory tissue, obtained surgically
17
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and from autopsies, have clearly demonstrated that the smooth 
muscle relaxation produced by electrical field stimulation in the 
presence of cholinergic blockade is unaffected by adrenergic 
antagonists (Richardson and Be land, 197 6? Davis et al. 1982).
The role of the sympathetic nervous system as a primary 
bronchomotor inhibitory mechanism in the human airway is 
therefore questionable. Furthermore, while it may be a 
significant bronchodilator mechanism in other species (Foster, 
19 6 4? Olsen et al. 1965? Cabezas et al. 1971? Richardson and 
Beland, 1976? Chesrown et al. 1980) , it has been suggested that 
the smooth muscle inhibitory responses obtained in these studies 
may relate to the release of norepinephrine from tl -■ perivascular 
nerves (Kirkpatrick, 1984). In any event, no similar results have 
been obtained with human tissue. It seems likely, therefore, that 
the physiological role of adrenergic fibres in the control of 
bronchomotor tone in man is insignificant despite their undoubted 
anatomical relation to airway smooth muscle. (Partanen et al. 
1982? Sheppard MN et al. 1983 ? Pack and Richardson, 1984? 
Laitinen A at al. 19 85a).
Although the precise role of sympathetic neurones in the 
control of airway glandular secretions is still undefined, recent 
studies in mammalian tracheal preparations have suggested the 
involvement in the secretory processes of adrenergic mechanisms 
(Borson et al. 19 80? Borson et al. 1984s Leikauf et al. 19 8 4).
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3.2 ADRENERGIC RECEPTORS
Adrenergic receptors were divided into two functional 
classes - alpha and beta - on the basis of the relative potency 
w.’th which they are stimulated by the various sympathomimetic 
amines (Ahlquist, 1948? Ahlquist, 1966). Subsequently, those 
adrenergic receptors with equipotent responses to epinephrine and 
norepinephrine, which are approximately 10-20% of that to 
isoproterenol, were designated beta-1 receptors. Those having 
responses to norepinephrine only 0.1-1% of the responses to 
isoproterenol were designated beta-2 receptors (Lands a t  al.
1967). Beta-1 and beta-2 receptors were further differentiated on 
the basis of the blocking potency displayed by selective beta- 
adrenergic antagonists such as practolol. By means of these 
principles it has been shown that the stimulation of beta—1 
adrenergic receptors is associated with a positive effect on 
cardiac chronotropy and inotropy as well as a lipolytic effect 
and that of beta-2 receptors with the inhibition of the tone of 
smooth muscle in various sites, including the airway (Lands et 
al. 1967).
Alpha-adrenergic receptors are those most potently 
stimulated by epinephrine and somewhat less by norepinephrine, 
displaying negligible responses to isoproterenol. They are 
further characterised by the fact that various adrenergic 
antagonists such as phenoxybenzamine and phentolamine demonstrate 
a greater affinity for them than for the beta-receptors. On the
basis of these principles it has been recognised that alpha- 
receptors are associated with a stimulatory effect on the tone of 
smooth muscle in various sites, most notably the vasculature.
More recently, the existence of two different subtypes of 
alpha-adrenergic receptor - designated alpha-1 and alpha-2 - has 
been confirmed. The alpha-1 subtype includes the conventional 
post-synaptic receptors such as those which mediate the 
contraction of vascular smooth muscle. Alpha-2 receptors, on the 
other hand, are presynaptic autoregu1atory sites on peripheral 
adrenergic nerve endings. The stimulation of alpha-2 receptors by 
the norepinephrine molecules released into the synaptic c ] -.f t 
reduces the degree to which continuing incoming neuronal impu; vs 
can stimulate further release of the neurotransmitter (Hoffman 
and Lefkowitz, 1980). There appear, in addition, to be alpha- 
adrenergic receptors in the central nervous system which, when 
stimulated, diminish peripheral sympathetic vascular tone 
resulting in a reduction in arterial blood pressure (van Zwieten, 
1973; Scriabine et a 1 . 19 7 6). These central receptors have
various characteristics in common with the peripheral alpha-2 
receptors (Berthe 1 sen and Pettinger, 1977; Miach et a 1 . 1978).
Among the alpha-adrenergic agonists, it has been suggested 
that methoxamine and phenylephrine are alpha-1 selective, and 
c 1onidine alpha-2 selective, and that epinephrine and 
norepinephrine which stimulate both subtype* or aIpha-receptor 
with equal potency, are relatively non-selactive (Berthe 1 sen and 
pettinger, 1977; Hoffman and Lefkowitz, 1980}, Among the alpha- 
adrenergic antagonists, prazosin and phenoxybenzamine are
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considered to be alpha-1 selective, yohimbine alpha-2 
se active, and pnentolarine relatively ’•on-selective (Cavero et 
a l .  1977; Doxey et a 1 . 1977? Hoffman and Lefkowitz, 1980).
Radioligand binding data using clonidine, yohimbine and 
alphamethyl-norepinep’’rine, and studies of alpha-agonist mediated 
inhibition of adeny j. cyclase and 3,5 cyclic adenosine 
monophosphate (3,5 cyclic AMP), have demonstrated that post- 
synaptic alpha-2 receptors exist in a wide variety of tissues 
(Wood et al. 1979; Exton, 1982).
3.2.1 Beta-Adrenergic Receptors
There is ample evidence of the existence of beta-receptors 
in the mammalian respiratory tract. Radioligand studies have 
demonstrated the presence of beta-adrenergic binding sites in 
respiratory tract tissue obtained from the rat, guinea-pig, 
rabbit and dog, as well as man (Furchgotu et al. 1975; Rugg et 
al. 1978? Minneman et al. 1979; Barnes at al. 1980d? Engel, 1981; 
Goldie et al. 1982; Carswell and Nahorski, 1983; Barnes et al. 
1983d; Brodda at al. 1983). The combination of this technique 
with studies utilising the known affinities of various adrenergic 
agonists and antagonists has permitted, in addition, the 
conclusion that the beta-1 and beta-2 receptor subtypes coexist 
in respiratory tract tissue (Furchgott et al. 1975? Rugg et al. 
1978? Minneman et al. 1979; Engel, 1981; Goldie et al. j.982; 
Carswell and Nahorski, 1983; Barnes et al. 1983d; Brodde et al. 
1983). Although beta-2 receptors appear to predominate, the 
proportions of the two subtypes appears to vary considerably
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between different species, and even possioly between differ tnt 
animals of the same species (Furchgott et al. 1975). The beta- 
l:beta-2 receptor ratio in human lung appears to be approximately 
30:70 (Engel, 1981; Brodde et al. 1983).
While clearly demonstrating that the mammalian respiratory 
tract contains a high density of beta-receptors, these studies 
permit no conclusions regarding their differential distribution 
among the numerous cell types and structures present in it. 
lanine tracheal muscle contains beta-receptor binding sites in a 
nsiderably lower density than a similar preparation of 
rtph'iral lung, suggesting the possible location of considerable 
„rti of beta-receptors in sites other than smooth muscle 
(Barnes et al. 1983d). The technique of light microscopic 
autoradiography has permitted the localisation of beta-receptors 
among the different cell types in the respiratory tract. In 
ferret lung, the highest density occurs in bronchiolar smooth 
muscle, with a somewhat lower density in the smooth muscle of 
large airways. Beta-receptors are also present in the airway 
epithelium, the submucosal glands, the vascular smooth muscle, 
and the alveolar walls (Barnes et al. 1982a).
A u t o r a d i o g r a p h i c  s t u d i e s  o f  h u m a n  l u n g s  o b t a i n e d  f r o m  
s u r g i c a l  p r o c e d u r e s  h a v e  s h o w n  t h a t  b e t a - r e c e p t o r s  a e a l s o  
w i d e l y  d i s t r i b u t e d  i n  m a n  ( C a r s t a i r s  e t  a l.  1984? C a r s t a i r s  e t  
a l .  1985). T h e  g r e a t e s t  d e n s i t y  a p p e a r s  t o  o c c u r  i n  t h e  a i r w a y  
e p i t h e l i u m ,  s u b m u c o s a l  g l a n d s ,  a n d  a l v e o l a r  w a l l s ,  w i t h  a l e s s e r  
d e n s i t y  i n  t h e  s m o o t h  m u s c l e  of b o t h  l a r g e  a n d  s m a l l  a i r w a y s  a n d  
i n  t h e  v a s c u l a t u r e .  C o m b i n a t i o n  w i t h  a g o n i s t  a n d  a n t a g o n i s  .
competition data show that the beta-1sbeta-2 receptor ratio is 
roughly 1:3, confirming the radioligand studies (Engel, 1981; 
Brodde et al. 1983). The beta-2 receptor is the exclusive subtype 
in the smooth muscle of both the large and the smal 1 airways, the 
vasculature, and the airway epithelium, while in both the 
submucosal glands and the alveolar walls, both receptor subtypes 
appear to co-exist (Carstairs et al. 1984, 1985).
These findings are consistent with the concept that beta- 
adrenergic receptors regulate numerous physiological processes in 
the respiratory tract other than airway smooth muscle tone. These 
include the inhibition of mast cell mediator release, the control 
of vascular smooth muscle tone, effects on the capillary 
endothelial cells and type II pneumocytes and the regulation of 
glandular mucus secretion (Barnes et al. 1984; Carstairs et al. 
1985). Evidence for the involvement of both beta-receptor 
subtypes in the latter function has been provided by the 
demonstration that both dobutamine and salbutamol increase the 
glycoprotein secretion in in vitro feline and human large airway 
preparations (Phipps et al. 1982; Peatfield and Richardson, 
1982). The significance of the high beta-receptor density in 
airway epithelium is uncertain. It is of considerable interest, 
however, that removal of the epithelium appears to increase the 
sensitivity of the smooth muscle to provoked constriction and to 
diminish the protective effect of bronchodi1ators in in vitro 
preparations (Flavahan et al. 1985; Barnes et al. 1985; Goldie et 
al. 1986). These rindings suggest the possible existence of a 
beta-adrenergies11 y mediated broi hodilator mechanism located
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within the airway epithelium. Beta-adrenergic agonists are also 
known to inhibit the release of mediators from human mast cells 
(Butchers et al. 1980; Peters et a 1 . 1982? Hughes et al. 1983). 
It is possible that mast cell beta-receptors which appear to be 
of the beta-2 subtype, (Butchers et al. 1980? Hughes et al. 1983) 
account, at least in part, for the high intra-epithelial density 
of these receptors.
3.2.2 Alpha-Adrenergic Receptors
The role of aIpha-receptors in the regulation of normal 
airway smooth muscle tone is considerably less well defined. 
Taking into account its effects in other sites, aIpha-receptor 
stimulation might be expected to result in airway smooth muscle 
contraction. There is little doubt, however, at least in health, 
that the predominant result of adrenergic stimulation of airway 
smooth muscle is the beta-receptor mediated inhibitory response. 
Thus, even such potent aIpha-agonists as norepinephrine and 
phenylephrine have, if anything, a slight bronchodilator effect 
in vitro, despite being extremely weak beta-agonists (Mathe et 
al. 1971? Goldie et al. 1984).
In 19 62 Castro de la Mata et al. showed that the 
administration of epinenephrine and norepinephrine, as well as 
sympathetic nerve stimulation, produced airway smooth muscle 
constriction in anaesthetised beta-adrenergically blocked dogs, 
the response being abolished by the aIpha-adrenergic blocker 
rolazoline. Subsequently, similar results were obtained In airway 
preparations in different mammalian species (Everitt and
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Cairncross, 19 69 ; Fleisch et a 1. 1970; Adolphson et a 1. 1971; 
Math® et al. 1971). The conclusion reached as a result of these 
studies was that alpha-adrenergic receptors were present in 
mammalian airways and could stimulate smooth muscle contraction. 
These findings were not, however, consistently demonstrable in 
vitro (Foster, 1966) or in vivo (Cabezas et al. 1971).
The results of in vitro studies of isolated human airway 
preparations likewise yielded conflicting results. Thus, the 
contraction of smooth muscle could be elicited with both 
epinephrine and norepinephrine in the presence of beta-blockade, 
the response being abolished by phenoxybenzamine (Adolphson et 
al. 1971), and being 10-20% of the maxima oronchoconstrictor 
responses elicited by cholinergic agonists or histamine (Maths et 
al. 1971; Simonsson et al. 1972). However, in another study, no 
increase in carbachol-induced contractions was obtained with 
epinephrine in the presence of propranolol, suggesting that 
a1pha-receptors were not present (Guirgis et al. 1969).
It has subsequently been demonstrated that the addition of 
alpha-adrenergic agonists to isolated tracheal and bronchial 
smooth muscle from human subjects with no evidence of respiratory 
disease, produces no contractile response unless the preparations 
have been pretreated with either potassium chloride or histamine 
(Kneussl and Richardson, 1978), and both in vitro and in vivo 
canine studies have produced similar results (Brown et al. 1983; 
Barnes et al. 1983e). However, in tissue from humans with 
evidence of significant respiratory disease, norepinephrine 
produces smooth muscle contraction without any pretreatment, the
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response being abolished by a 1pha-b1ockade (Kneussl and 
Richardson, 1978). Similarly, beta-adrenergic blockade appears to 
potentiate the contractile response of canine tracheal smooth 
muscle to alpha-stimulation (Leff et a 1 . 1986). It is possible 
that alpha-receptors are present in respiratory tract tissue and 
are in some way activated in the presence of an abnormality or 
disease process.
Radioligand studies using (3H)prazosin have confirmed the 
presence of a 1pha-receptor binding sites in homogenised human 
lung tissue (Barnes et al. 1980d). Although the distribution of 
these receptors in the human respiratory tract has not yet been 
clearly defined, autoradiographic distribution studies in ferret 
lung using the same radioligand have shown that alpha-1 receptors 
are relatively widely distributed, being present in a high 
density in the vascular smooth muscle and the smooth muscle of 
tne peripheral airways. Lesser densities occur in the airway 
glands, epithelium and alveolar wans, and few alpha-1 receptors 
are present in the large airways (B"rnes et al. 1983a; Barnes et 
al. 198 3b). Radioligand studies with (3H)prazosin and 
(3H)yohimbine in canine tissue suggest that tracheal alpha- 
receptors are predominantly of the alpha-2 subtype (Barnes et al. 
19 8 3s; Barnes «t al. I983f), whereas the alpha-1 subtype 
predominates in the peripheral lung (Barnes et al. 1983f). The 
contractile response to electrical field stimulation off beta- 
adrenergically and cholinergically blocked tracheal smooth muscle 
is more potently inhabited by yohimbine than by prazosin. In 
addition, the alpha-2 agonist clonidine appears to bu the most
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potent aIpha-agonist in contraction studies and in competition 
with the selective alpha-2 antagonist ligand (3H)yohimbine. These 
data confi m the presence of a significant number of alpha-2 
receptors in the canine trachea (Barnes et al. 1983f).
The above data suggest that alpha-receptors are present in 
human airway smooth muscle, but precise knowledge of receptor 
subtypes and of their role in the regulation of smooth muscle 
tone, both in health and disease is, for the most part, lacking. 
Evidence for the involvement of alpha-receptors in the regulation 
of mucous glandular secretion has been provided by studies 
showing that phenylephrine and norepinephrine increase the rate 
of glycoprotein secretion in the feline and human large airway 
(Shelhamer et al. 1980a; Phipps et al. 1 9 6 Peatfield and 
Richardson, 1982). Studies in the cat suggest, in addition, that 
alpha-adrenergically mediated bronchial glandular secretions may 
be more watery than those stimulated by beta-adrenergic agonists 
(Leikauf et al. 1984).
A study of canine mast cells has provided no evidence of the 
existence in them of alpha-adrenergic receptors 'Phillips et al.
1985).
3.3 ENDOGENOUS CIRCULATING CATECHOLAMINES
3.3.1 Epinephrine
Epinephrine is a product of tyrosine metabolism being 
synthesised from norepinephrine in the chromaffin cells which 
contain the enzyme pheny 1 ethano 1 amine-N-methy 1 transferase. In
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post-natal life the bulk of these cells are found in the adrenal 
glands where they constitute the adrenal medullae. Bilateral 
adrenalectomy in humans results in a fall in the plasm" 
concentration of epinephrine to undetectable levels even in the 
presence of insulin-induced hypoglycaemia, normally a potent 
stimulus to its secretion (Cryer, 1976). The rate of synthesis of 
tyrosine to norepinephrine in the adrenal medullae appears to be 
mainly regulated by sympathetic neuronal discharges, and the rate 
of conversion of norepinephrine to epinephrine mainly by 
adrenocorticotropic hormone and corticosteroids (Axelrod and 
Weinshllboum, 1972). Epinephrine is stored in granules within the 
chromaffin cells and released by the process of exocytosis at a 
basal rate of about 0.2/ug/kg/min (Guyton, 1981b). Sudden surges 
in the rate of secretion occur as a result of increased neuronal 
discharges in the preganglionic sympathetic supply to the adrenal 
medullae, these being part of the generalised adrenergic response 
to such stimuli as fear, rage, exercise, hypoxaemia, hypo­
glycaemia and shock.
Epinephrine is more potent than norepinephrine in its 
effects on alpha-adrerergic receptors, but less potent than 
isoproterenol in its effects on beta-receptors (Ahlquist 1966). 
It is also more potent in its bronchodilator and vasodilator - 
beta-2 adrenergic - effects than in its lipolytic and cardiac 
stimulatory - beta-1 adrenergic - effects (Lands et al. 1967) .
The combined data from a number of studies suggest that mean 
basal levels of plasma epinephrine in normal supine human 
subjects are approximately 20-50pg/ml (conversion to nmol/1 x
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0.0055) (Cryer, 1976). Plasma epinephrine levels normally exhibit 
a circadian variation with peak levels occurring at about 16h00 
and trough levels at about 04h00 (Barnes at al. 1980b).
Epinephrine functions as a circulating hormone mediating 
diverse adrenergic functions throughout the body, and its effects 
on the respiratory tract include the beta-adrenergically mediated 
inhibition of airway smooth muscle tone. Infusions achieving 
plasma levels close to the normal physiological range are 
associated with a rise in both heart rate and systolic blood 
pressure, a fall in diastolic blood pressure, a variety of 
characteristic metabolic changes, and a significant increase in 
specific airway conductance (Fitzgerald et al. 1980; Warren and 
Da 1 ton, 1983). In both asthmatic patients and normal subjects 
epinephrine has been shown to reverse the bronchospasm provoked 
by various stimuli (Warren et al. 1984; Sands et al. 1985; 
Larsson et al. 1985).
3.3.2 Norepinephrine
Synthesis of norepinephrine from tyrosine via the compounds 
dihydroxyphenylalanine and dopamine takes place both in the 
central nervous system and in the axon terminals of peripheral 
postganglionic sympatnetic neurones. In addition, a significant 
concentration gradient of norepinephrine exists from the adrenal 
veins to the inferior vena cava and norepinephrine is estimated 
to constitute as much as 20% of the total catechol amine 
production of the adrenal medullee, being secreted at a rate of 
0.05 yug/kg/min (Guyton, 1981b). Despite this, bilateral
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adrenalectomy appears to have little effect on basal plasma 
norepinephrine levels (Cryer, 1976). Norepinephrine is released 
from postganglionic sympathetic neurones as a result of neural 
activity. It is a potent alpha-adrenergic agonist being, however, 
less potent than epinephrine in its effect on alpha-receptors 
(Ahlquist, 1966). It is equipotent with epinephrine in its effect 
on beta-1 receptors, and has little effect on beta-2 receptors 
(Lands et a 1 . 1967).
The combined data obtained from a number of studies suggest 
that the basal plasma norepinephrine levels of normal supine 
subjects are approximately 200-220pg/ml (conversion to nmol/1 x 
0.0059);Cryer, 1976). The excess of plasma norepinephrine over 
epinephrine levels may be related to a greater rate of release 
combined with a slower rate of clearance from the circulation 
(Fitzgerald et al. 1980). Although an infusion of norepinephrine 
administered to normal subjects produces significant haemodynamic 
and metabolic effects, these are only evident with plasma levels 
considerably in excess of resting values (1800pg/ml), suggesting 
that in the absence of significant stress, such as that related 
to prolonged or maximal exercise or a major acute illness, 
norepinephrine functions as a neurotransmitter only (Silverberg 
et al. 1978). It has recently been demonstrated that neither 
norepinephrine nor phenylephrine cause adrenergic metabolic 
effects or significant broncnodilatation in either asthmatic or 
non-asthmatic subjects despite significant increments in blood 
pressure (Bvsrkin et al. 1986? Larsson et al. 1986).
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3.3.3 Circulating Catecholamines and The Human Airway
Barnes at al (1983d) have shown that whereas both beta-1 and 
beta-2 receptors are present in canine tracheal smooth muscle in 
a ratio of 1:4 respectively, the relaxation response to beta- 
agonists is mediated mainly by the beta-2 receptors with only a 
small contribution from the beta-1 subtype. The relaxation 
response to norepinephrine released by electrical sympathetic 
nerve stimulation is, on the other hand, predominantly mediated 
by the beta-1 receptors. While both beta-1 and beta-2 receptors 
undoubtedly co-exist in the human lung (Engel, 1981; Goldie et 
al. 1982; Brodde et al. 19 8 3; Carstairs et al. 19 85) , the beta- 
receptors in human airway smooth muscle appear to be exclusively 
off the beta-2 subtype (Carstairs et al. 1985). The lack of a 
significant functional sympathetic nerve supply and the apparent 
lack of beta-1 receptors in human airway smooth muscle suggest, 
therefore, that the adrenergic inhibitory modulation of its tone 
is primarily mediated by the effect of circulating epinephrine on 
the high density of beta-2 receptors present in both lar ,e and 
small airways (Carstairs at al. 1985). However, while relatively 
small doses of propranolol have been shown to cause some increase 
in airway resistance in non-asthmatic individuals (MacDonald et 
al. 1967), the lack of a consistent effect of beta-blockade on 
the calibre of the normal human airway raises some doubts about 
the physiological importance of this mechanism in man, at least 
in health (Zaid and Beall, 1966; Richardson and Sterling, 1969; 
"attersffield et al. 1973).
mCHAPTER 4
NON-ADRENERGIC NON-CHOLINERGIC MECHANISMS
4.4* A ■
4.1 NON-ADRENERGIC NON-CHOLINERGIC NERVES
It has been known for some time that non-adrenergic non- 
: h o l i n , r g i c  (NAMC) f i b r e ,  e x i s t  I n  t h e  g a s t r o i n t e s t i n a l  t r a c t ,  
and urogenital systems of various mammalian species (Burnstook, 
1972). NANC fibres inhibit gastrointestinal smooth muscle to n e ,  
o u t  a p p e a r  t o  b e  e x c i t a t o r y  i n  t h e  u r o g e n i t a l  s y s te m .  The  
presence in the mammalian r e s p i r a t o r y  tract of a NANC system has  
been  c o n f i r m e d  i n  a number o f  a n i m a l s ,  i n c l u d i n g  t h e  g u in e a - p i g  
(Coburn and Tomita, 1973; Richardson and Bouchard, 1975), the cat 
(Irvin e t  al. 1980) and t h e  cow (Palmer e t  al. 1985b). The 
e x i s t e n c e  of the NANC s y s te m  in man h as  been convincingly 
confirmed in lungs o b ta in e d  fro m  surgical e x c i s i o n s  and a u to p s ie s  
(Richardson and B e l a n d ,  1976; Davis et al. 1982; Palmer et al.
1986a).
The NANC inhibitory system in the gastrointestinal tract has 
been shown to migrate with cholinergic fibres in rodent foetuses 
and to be functional significantly earlier in foetal life than 
t h e  a d r e n e r g i c  s y s t e m  ( G e r . h o n  a n d  T h o m p s o n ,  1973). It i s  
p o s s i b l e  t h a t  t h i s  p a t t e r n  a p p l i e s  as w e l l  d u r in g  t h e  d e v e lo p m e n t  
o f  t h e  r e s p i r a t o r y  t r a c t .  The NANC i n h i b i t o r y  e f f e c t ,  on a i r w a y  
smooth m u s c le  tone e l i c i t e d  in intact cholinergically blocked 
a n i m a l ,  b y  e l e c t r i c a l  v a g a l  s t i m u l a t i o n  (Chesrown e t  a l .  1980; 
Irvin et al. 1980; Diamond a n d  O'Donnell, 1980) can be 
c o n s i d e r a b l y  a t t e n u a t e d  by i n t e r r u p t i o n  of the recurrent 
laryngeal n e r v e s  an d  b y  the a d m i n i s t r a t i o n  of h e x a m e th o n iu m  
(Diamond and O'Donnell, 1980). T h e s e  findings suggest that t h e
anatomical location of the NANC preganglionic fibres is within 
the vagal trunks. It appears from electrical field studies that 
NANC fibres are present from the mid-trachea 1 level to that of 
the distal bronchi, suggesting that postganglionic NANC fibres 
are widely distributed throughout the airways (Richardson and 
Beland, 1976). However, tantalum Bronchography in cats suggests 
that while the NANC system inhibits bronchomotor tone from the 
trachea to the small airways, it has the most effect on those 
with a diameter of 4mm (Matsumoto et al. 1985). S*vlx:3 in 
human tissue have .own that in contrast to the more central 
airways, the bronchioles have little NANC innervation (Palmer et 
al. 1986a).
NANC mechanisms appear, in addition, to be involved in the 
control of the secretions of the airway glands. This has been 
suggested by the finding that electrical field stimulation 
increases the secretion of radiolabelled macromolecules by the 
submucosal glands of the isolated ferret trachea in the presence 
of cholinergic and adrenergic blockade (Borson et al. 19b4) .
4,2 NBOROTRANSMITTERS OF THE NON-ADRENERGIC NON-CHOLINERGIC
NERVOUS SYSTEM
4,2.1 Vasoactive Intestinal Polypeptide
The neurotransmitters of the NANC system have not been 
identified with certainty. Burnstock (1972) thought that 
adenosine triphosphate was involved, ai. accordingly used the 
term "purinergic" to describe the system. This postulate could
not, however, be substantiated in a number of later studies (Ito 
and Takeda, 1982; Cameron et al. 1983).
A considerable amount of experimental evidence has now been 
accumulated suggesting that the inhibitory neurotransmitter of 
the NANC system is vasoactive intestinal polypeptide (VIP). The 
relaxation by VIP of isolated bovine (Cameron et al, 1983; Palmer 
et al. 1985b) and guinea-pig tracheal smooth muscle (Said et al.
1974) has been clearly demonstrated. In isolated precontracted 
feline trachea I smooth muscle, the amplitude of electrically- 
induced relaxation can be significantly diminished by prior 
partial desensitisation to VIP (Ito and Takeda, 1982). All these 
effects appear to be unrelated to either cholinergic or 
adrenergic mechanisms, suggesting therefore that the effect of 
VIP is similar to that of NANC nerve stimulation.
VIP has been shown to be released during the electrical 
stimulation of intrinsic airway nerves in both bovine and guinea- 
pig preparations (Matsuzaki et al. 1980; Cameron et al. 1983) in 
an amount correlating with the degree of smooth muscle relaxation 
induced, and prior incubation with VIP-antiserum significantly 
reduces this response (Matsuzaki et al. 1980). VIP is equipotent 
with isoproterenol in its inhibitory effect on the smooth muscle 
of the isolated feline large airway (Altiere and Diamond, 1984) 
and has a considerably greater effect than isoproterenol on human 
bronchi of 3-4mm diameter (Palmer et al. 1986a). It has little 
effect, however, on bronchioles (Palmer et al. 1986a).
The peptide has been shown by both radioimmunoassay and 
immunocytochemical techniques to exist within the autonomic
nerves of the airway walls in various mammalian species, 
including man (Dey et a 1. 1981; Polak and Bloom, 1982; Hakanson 
et a 1 . 1983; Sheppard MN et a 1 , 1983; Laitinen A et a 1. 1985b) 
and is detectable in the human foetus after 20 weeks of gestation 
(Sheppard et al. 1984a). It is closely associated not only with 
airway smooth muscle, but also with mucous glands and pulmonary 
and bronchial blood vessels, suggesting its probable involvement 
in the regulation of secretory processes and vascular and airway 
smooth muscle tone. Its involvement in the control of airway 
glandular secretions has been confirmed by the finding that it 
has a direct effect on the stimulation of the output of labelled 
macromolecules by ferret submucosal glands (Peatfield et al.
1983), and increases the transport of chloride ions across the 
canine tracheal epithelium (Nathanson et al. 1983). VIP has also 
been shown to have a far more potent relaxant effect than 
isoproterenol on the feline pulmonary artery (Hamasaki et al.
1983). In minced guinea-pig lung it inhibits antigen-induced 
histamine release suggesting a possible effect on mast cells
(Ondem et al. 1983).
The suggestion that VIP is involved in diverse aspects of 
p u l m o n a r y  function has been strengthened by recent 
autoradiographic studies demonstrating the presence of VIP 
receptors in the epithelium, submucosal glands, vascular smooth 
muscle, alveoli and smooth muscle of large - but not small 
airways in the guinea-pig lung (Carstairs and Barnes, 1986b).
The mode of action of VIP may be similar to that of beta- 
adrenergic agonists in that it has been shown to induce the
accumulation of 3,5 cyclic adenosine monophosphate (3,5 cyclic 
AMP) in the guinea-pig trachea (Frandsen et al. 1978) as well as 
in the tracheal submucosal glands of ferrets and the epithelial 
cells of the canine trachea (Lazarus et al. 1983). It has also 
been shown to stimulate the adenyl cyclase activity of rat lung 
more potently than either beta-adrenergic agonists or 
prostaglandins (Robberecht et al. 1981). It has been suggested, 
however, that VIP mediates the stimulation of salivary gland 
secretion in cats by enhancing the binding of muscarinic agonists 
to receptors (Lundberg et al. 1982) and that it may inhibit the 
contractile effect of acetylcholine on bovine tracheal smooth 
muscle by a post-receptor mechanism (Palmer et al. 1985b).
Despite all this evidence, however, and despite the potent 
bronchodilator effect of VIP in intact animals (Diamond et al.
1983) and isolated human airway smooth muscle (Palmer et al. 
1985a; Palmer et al. 1986a), in vivo human studies have yielded 
somewhat less convincing results. Inhaled VIP has little effect 
on the specific airway conductance in asthmatic patients, and 
diminishes the bronchoconstrictor response to histamine far less 
than inhaled salbutamoi (Barnes and Dixon, 1984). Intravenous VIP 
appears to diminish the contractile response to inhaled histamine 
(Morice et al. 1983), but has, at most, a small bronchodilator 
effect (Morice et al. 1983; Palmer et al. 1986b). It has been 
suggested that these somewhat disappointing results may relate 
either to the fact that the neurotransmitter has not been 
delivered to the target organ, namely smooth muscle, by the 
normal physiological route (Barnes and Dixon, 1984) or to its
rapid enzymatic breakdown (Palmer et al. 1986b).
In addition to VIP, another closely related peptide found in 
human airway nerves - peptide histidine methionine - appears to 
be a potent smooth muscle relaxant, at 1east in vitro (Palmer et 
al. 1986a).
4.2.2 Other Regulatory Polypeptides
A considerable number of other regulatory peptides have been 
shown to be present in mammalian airways. These include bombesin, 
cholecystokinin, somatostatin, ca 1 citonin-gene-re 1 ated-peptide, 
galanin, neuropeptide tyrosine and substance P (Polak and Bloom, 
1982; Cutz, 1982; Hakanson et al. 1983; Pernow, 1983; Sheppard et 
al. 1984b; Palmer et al. 19 8 5c; Cheung et al. 1985), the latter 
being of particular interest. It appears to be present in fibres 
originating from the vagal trunks (Pernow, ,1983), and has been 
demonstrated, in addition, in the nerve fibres of human airways 
where it is related to smooth muscle, epithelium and blood 
vessels (Sheppard MN et al. 1983), although some workers have 
been unable to confirm its presence (Laitinen et al. 1983). 
Substance P produces a dose-dependent contraction of human 
bronchial smooth muscle in vitro, which is resistant to atropine 
and appears, therefore, not to be cholinergically mediated 
(Lundberg et al. 1983). In addition to its effect on airway 
smooth muscle, it appears to stimulate the secretion of 
macromolecules by canine trachea 1 glands (Baker et al. 1977; 
Coles et al. 1984) with a potency far in excess of that of 
methacholine (Coles et al. 1984), and also specifically to
increase the secretion of chloride ions (Al-Bazzaz et a 1. 1985).
Both substance P and calcitonin-gene-related-peptide pro­
duce a wheal-and-flare reaction following intradermal injection 
into humans which is associated with, but not dependent upon, 
dermal histamine release (Barnes et a 1. 1986a,‘Barnes et a 1. 
1986b). It has been postulated that axon reflexes resulting from 
epithelial damage to the airway may cause the release of 
neuropeptides from sensory fibres (Barnes, 1986).
It appears likely, therefore, that substance P is a 
neurotransmitter of a NANC excitatory system, and substance P 
receptors have recently been identified by autoradiographic 
studies in the airways and lungs of both the guinea-pig and man 
(Carstairs and Barnes, 1986a). In addition, however, another 
peptide, eledoisin, has been shown to be even more potent in its 
in vitro contractile effect on human airway smooth muscle 
(Karlsson and Persson, 1985).
As with VIP, there is evidence suggesting possible 
interaction of substance P with other components of the autonomic 
nervous system. It has been suggested that the contractile effect 
of the peptide on rabbit tracheal smooth muscle in vitro, is 
mediated by an acceleration in the release of acetylcholine from 
parac Tmpathetic nerve endings (Tanaka and Grunstein, 1984; Tanaka 
and Grunstein, 1985) . In addition, it has been demonstrated that 
NANC-mediated contraction of the guinea-pig trachea is inhibited 
by norepinephrine and antagonist studies ha'"' suggested that it 
may be associated with alpha-2-receptors (Grundstrom et al,
i'4/.'
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In conclusion, the NANC system appears to be an important 
component of the autonomic regulatory control of airway smooth 
muscle tone and airway glandular secretion. Apparent 
a b n o r m a l i t i e s  of the NANC inhibitory system in the 
gastrointestinal tract have been linked to Hirschprung's disease 
(frigo et al. 1973), and it has also been suggested that NANC 
abnormalities are associated with disorders of the urinary 
bladder (Polak and Bloom, 1983). No abnormalities of the system 
have yet been described in association with bronchial asthma.
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CHAPTER 5
MOLECULAR MECHANISMS INVOLVED IN RECEPTOR FUNCTION
The combination of specific molecules of either endogenous 
origin - for example hormones and neurotransmitters - or 
exogenous origin - for example pharmacological agents - with 
receptors on the surfaces of cells, initiates intracellular 
events such as the activation of enzyme systems or alterations in 
ion fluxes, which ultimately result in characteristic 
physiological effects. Beta-receptors of both subtypes are 
associated with a specific biochemical system involving the 
catalytic enzyme adenyl cyclase which converts the substrate 
adenosine triphosphate (ATP) to 3,5 cyclic adenosine 
monophosphate (3,5 cyclic AMP). As this system has been
extensively studied and is involved as well in the function of
both alpha-2 receptors and muscarinic receptors, it is convenient 
to deal with beta-receptor function first.
5.1 BETA-ADRENERGIC RECEPTORS
5.1.1 Activation of Beta-Adrenergic Receptors
Hormone sensitive adenyl cyclase activity is present in 
virtually all animal cells and can be either stimulated or 
inhibited by a large number of different hormones and drugs, i e 
components of the system include:
(i) The receptor.
(ii) The catalytic moiety of adenyl cyclase.
(iii) A guanine nucleotide regulatory coupling protein (G- 
protein).
This exists in two structurally similar forms, namely: (a) &
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stimulatory form which allows the coupling of adenyl cyclase 
to beta-1 and beta-2 receptors, (b) an inhibitory form which 
allows coupling to alpha-2 receptors. Both of these 
regulatory molecules are multi—subunit proteins sharing in 
common two subunits, namely the beta-subunit of molecular 
weight 35,000 Daltons, and the gamma-subunit of molecular 
weight 8,000 Daltons. The alpha-subunits of the two forms of 
G-protein differ, the molecular weight being 45,000 Daltons 
in the stimulatory protein, and 41,000 Daltons in the 
inhibitory protein (Gilman, 1984). Furthermore, the alpha- 
subunit of the stimulatory protein provides a substrate 
for adenosine diphosphate (ADP)-ribosylatlon by cholera 
enterotoxin (Moss and Vaughan, 1979), whereas the alpha- 
subunit of the inhibitory regulatory protein provides a 
substrate for ADP-ribosylation by B. pertussis toxin (Katada 
i t  al. 1984).
(iv) Guanine nucleotides such as guanosine triphosphate(GTP).
4
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This entire system is found in the cellular plasma membrane 
and the combination of an agonist molecule with the beta-receptor 
results, after a number of coupling processes, in the stimulation 
of adenyl cyclase followed by an increase in the intracellular 
level of 3,5 cyclic AMP (Lefkowitz et al. 1983? Lefkowitz et al.
1984) .
It has been shown that while antagonists bind to the beta- 
receptors on frog erythrocyte membranes with uniform affinity, 
agonists exhibit states of either high or low affinity (Kent et
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al. 1980). The high affinity state appears to be converted to one 
of low affinity by guanine nucleotides (Kent et al. 1980). 
Agonist occupancy of the beta-receptor appears to result in a 
physical coupling of the receptor itself to the G-protein. This
reaction does not occur; however, after receptor occupancy by an
antagonist (Limbird et al. 1980a). The affinity of the receptor-G 
protein comp 1 ex for agonists is greater than that of free 
receptors , and it has been suggested, therefore, that the complex 
represents the high affinity form of the beta-receptor and the 
free receptor the low affinity form. Furthermore, the ability of 
an agonist to activate adenyl cyclase correlates closely with the 
degree of high affinity agonist-beta-receptor binding (Kent et 
al. 1980), giving credence to the suggestion that the formation 
of a high affinity ternary complex is a necessary intermediate 
step in the activation of adenyl cyclase (De Lean et al. 1980).
GTP appears to be essential for hormone adenyl cyclase
responsiveness (Ross et al. 1977) and it has been suggested that
catecholamines may promote the release of guanosine diphosphate 
(GDP) from the G-protein, thereby vacating a binding site for GTP 
(Cassel and Selinger, 1978). It is currently believed that GTP 
binds to the ternary agonist-receptor-G protein complex, 
activating and dissociating the G-protein, with simultaneous 
formation of the low affinity free receptor (Lefkowitz et al. 
1904). The activated G-protein-GTP complex then itself activates 
the catalytic moiety of adenyl cyclase.
It has been suggested that the activation of beta-receptors 
leads ultimately to a dissociation of the alpha-subunit from the
beta- and gamma-subunits of the stimulatory G-protein and that 
the alpha-subunit then provides the stimulus for adenyl cyclase 
activation (Gilman, 1984). The series of reactions is terminated 
by the eventual hydrolysis of GTP to GDP by a hydrolytic GTPase 
activity. This reaction appears to br dependent on receptor 
occupancy by agonist uut is unrelated to a catalytic adenyl 
cyclase effect. The GTPase reaction appears to be slower than 
adenyl cyclase activation, and ultimately permits the return of 
the system to the inactive state (Cassel and Selinger, 1976). The 
latter reaction is inhibited by cholera enterotoxin thereby 
resulting in a marked enhancement of adenyl cyclase activity 
; Cassel and Selinger, 1977? Moss and Vaughan, 1979).
5.1.2 Th Mediation of Smooth Muscle Relaxation by 
Beta-Adrenergic Receptors 
protein kinases in diff .ent types of muscle cells, 
including smooth muscle, are sensitive to the intracellular 
levels of 3,5 cyclic AMP. These enzymes are composed of 
regulatory and catalytic subunits with the former inhibiting the 
activity of the latter. 3,5 cyclic AMP binds to the regulatory 
subunits thereby effecting a functional dissociation between the 
two moieties such that catalytic activity is no longer inhibited. 
The a c t i v a t e d  enzyme can then initiate a series of 
phosphory1 at ion reactions which ultimately result in typica 1 
beta-adrenergic effects In different cell types (Robison et al. 
1971) .
It is currently believed that smooth muscle relaxation may
b® effected by one or both of two mechanisms, namely: (i) A
limitation of the availability of free calcium ions to the 
contractile apparatus of muscle cells, (ii) Inhibition of the 
interaction between actin and myosin due to the phosphorylation 
of myosin light chain kinase.
(i) Limitation of the availability of calcium ions: A
considerable body of evidence suggests that changes in myoplasmic 
free calcium ion levels result in the contraction and relaxation 
of smooth muscle as well as other types of muscle cells. When 
intracellular calcium levels reuch 10 ® molar, calcium binds to a 
protein with a molecular weight of 16,500 Daltons, known as 
calmodulin. The calcium-calmodulin complex binds to and activates 
myosin light chain kinase, and the activated enzyme can then 
phosphory1 ate the light chain of my' sin. This permits the 
interaction of myosin and actin which results in muscle 
contraction (Adelstein and Hathaway, 1979; Braunwa1d 1982). In 
the presence of Intracellular calcium levels of 10 ® molar or 
less, calmodulin cannot bind to myosin light chain kinase. The 
enzyme therefore remains inactive and muscle contraction cannot 
occur (Adelstein and Hathaway, 1979).
The importance of calcium ions in the process of smooth 
muscle contraction is demonstrated by the fact that the ability 
of 3,5 cyclic AMP to relax guinea-pig bowel is inversely related 
to the concentration of both calcium ions and calmodulin 
(Meisheri and Rugg, 1983). A reduction in the myoplasmic free 
calcium ion activity has been shown to occur as a result of a 
number of different mechanisms mediated by beta-adrenergic
agonists or 3,5 cyclic AMP. These include the intracellular 
sequestration of calcium ions, cellular calcium ion extrusion and 
the inhibition of entry of calcium ions into cells. There is 
experimental evidence supporting each of these mechanisms 
(Tomiyama et al. 1973; Kroeger et a 1. 1975; Mueller and van 
Breemen, 19 79; Btilbring and den Hertog, 1980; Meisheri and van 
Breemen, 1982; Cauvin et al. 1984).
While it appears that beta-adrenergic receptor activation 
may relax smooth muscle by a reduction in the myoplasmic calcium 
ion level, the effect being mediated by 3,5 cyclic AMP, the 
precise mechanisms involved remain undefined. It is possible that 
relaxation is related to the activation of protein kinases which 
can then phosphorylate proteins involved in the regulation of 
intracellular calcium ion levels.
(ii) The phosphorylation of myosin light chain kinase: A 
considerable amount of evidence suggests that beta-adrenergic 
receptor stimulation results in smooth muscle relaxation by an 
effect on the myosin light chain kinase system which mediates the 
interaction of actin and myosin thus permitting muscle 
contraction (Ade1 stein and Hathaway, 1979). The incubation of 
avian myosin light chain kinase with the catalytic unit of 3,5 
cyclic AMP-dependent protein kinase results in the incorporation 
of a mole of phosphate per mole of myosin light chain kinase. 
This, in turn, causes a two-fold diminution in the rate at which 
the enzyme phosphorylates the light chain of smooth muscle myosin 
(Ade1 stein et al. 19 78). It has been suggested that the 
diminished activity of phosphorylated myosin light chain kinase
results from its inability to bind tightly to calmodulin (Conti 
and Adelstein, unpublished observations, cited in Adel stein and
Hathaway, 1979).
It has been demonstrated that c a l c i u m - d e p e n d e n t  
phosphorylation of the light chain of myosin is depressed by 3,5 
cyclic AMP in the presence of protein kinases (Silver and 
DiSalvo, 1979), the reaction being attenuated by the addition of 
calmodulin (Silver et al. 1981), suggesting its relation to a 
shift in the calcium sensitivity of the -ystem. In addition, the 
rate and extent of both tension d e v e l o p m e n t  and the 
phosphorylation of the myosin light chain induced by carbachol in 
bovine tracheal muscle can be inhibited by prior incubation with 
isoproterenol (Silver and Stull, 1982). Similarly, calcium-ion- 
activated tension in avian smooth muscle has been shown to be 
inhibited by pretreatment with the catalytic unit of protein 
kinase. This apparent reduction in calcium sensitivity can be 
reversed by the addition of calmodulin, and the rate of 
inhibition of tension increased, moreover, by the addition of 3,5 
cyclic AMP (Kerrick and Hoar, 1981).
As a result of these and other studies, it has been 
hypothesised that beta-receptor stimulation results in the 
activation of 3,5 cyclic AMP and, therefore, in turn, to the 
activation of 3,5 cyclic AMP-dependent protein kinases. These 
phosphory1 ate myosin light chain kinase lowering its affinity for 
the calcium ion-ca1modu1 in complex. The final result is a 
reduction in myosin phosphorylation associated with diminished 
interaction with actin and the inhibition of muscle contraction.
xt 1. pos.Ibis that 3,5 cyclic AMP may act by an integrated 
mechanism both lowering the intracellular calcium ion 
concentration and inhibiting the phosphorylation of myosin light 
chain kinase, both of Which mechanisms result in the relaxation
of smooth muscle.
It must be emphasised that the data on which these
hypotheses are based have been obtained from in vitro studies in
anima. preparations of smooth muscle, often originating,
moreover, from site, other than the airway. Their applicability,
therefore, to the physiology of the airway smooth muscle in man
r e m a i n s  l a r g e l y  u n p r o v e d .
5 . 2 ALPHA-ADRENERGIC RECEPTORS
The intracellular molecular event, which follow ligand 
binding to alpha-r.c.ptors are, in general, not as well 
understood as those associated with binding to beta-receptors. It 
is clear from both radioligand binding studies and physiological 
data, that alpha-1 and alpha-2 receptors are distinct entities. 
A. discussed above (Chapter 3.2.2), alpha-1 receptor, appear to 
be exclusively pc.t.ynaptic, whereas alpha-: receptor, exist in 
b o t h  p r e s y n a p t i c  a n d  p o s t s y n a p t i c  s i t e s .
5.2.1 A c t i v a t i o n  of AlPha-1 A d r e n e r g i c  R e c e p t o r s
The binding protein of alpha-1 receptors has recently been 
identified using a r.dio-iodin.t.d structural analogue of 
prazosin (Le.b-Lundberg et al. 19 = 4). Their activation appear, to
be associated with effects on both cellular calcium ion fluxes 
and phospholipid metabolism, and alpha-1 receptors have been 
identified and specifically related to these effects in a wide 
variety of tissues (Michel 1 , 1975; Exton, 1982).
(i) The role of calcium ions: Much of the current understanding 
of alpha-1 receptor function is based on studies of 
adrenergically mediated glycogen breakdown in rat liver cells. It 
has been shown that both alpha- and beta-adrenergic agonists 
mediate an increase in hepatic glucose output related to the 
activation of glycogen phosphorylase - the rate limiting step in 
hepatic glycogenolysis. However, whereas this glycogenolytic 
reaction is associated with an increase in intracellular 3,5 
cyclic AMP levels when beta-adrenergically mediated, it appears 
to be 3,5 cyclic AMP-independent when stimulated by alpha- 
agonists (Sherline et al. 1972; Osborn, 1975). In addition, 
cyclic A M P - i n d e p e n d e n t  pho s p h o r y l a s e  a c t i v a t i o n  and 
glycogenolysis appear to be calcium ion-dependent, the process 
being impaired in the presence of intracellular calcium ion 
depletion (van de Werve et al. 1977; Assimacopoulos-Jeannet et
al. 1977; Blackmore et al. 1978).
Studies of hepatocyte calcium homeostasis have shown that 
phenylephrine increases the cytosolic free calcium ion 
concentration, the time course and dose-response relationship 
being closely paralleled by an increase in the intracellular 
levels of phosphorylase. These effects appear, moreover, to be 
antagonised by alpha-adrenergic blockade (Murphy et al. 1980). 
Phenylephrine retains its calcium mobilising effect, but fails to
activate phosphorylase in a strain of rat with deficiency of the 
enzyme phosphorylase kinase (Blackmore and Exton, 19 81). It is 
currently believed, therefore, that the alpha-adrenergically 
mediated rise in the cytosolic calcium ion level initiates a 
glycogenolytic reaction, with the most likely site of action 
being at the level of this enzyme (van de Werve et al. 1977; 
Assimacopoulos-Jeanet et al. 1977; Blackmore et al. 1978; Kunos,
1984). Phosphorylase kinase can, in addition, be shown to be 
stimulated by calcium ions (Shimazu and Amakawa, 1975).
The rise in the cytosolic free calcium ion level that occurs 
in response to alpha-adrenergic stimulation, may be the result of 
the mobilisation of calcium from intracellular pools, and/or of 
the influx of extracellular calcium. A norepinephrine-responsive 
calcium pool appears to be located in the mitochondria of 
hepatocytes (Babcock et al. 1979). However, more recently it has 
been suggested that it is a non-mitochondria 1 vesicular pool of 
calcium that is involved (Streb et al. 1983; Joseph et al. 1984), 
and the exact source of alpha-adrenergically responsive calcium 
ions remains undefined. Most of the calcium released into the 
cytosol appears to be rapidly extruded from the cells following 
the initial rise in intracellular levels, reaccumulating once 
the effect of the agonist is terminated (Kunos, 1984).
(ii) The role of phospholipids: It appears unlikely that 
intracellular organelles respond directly to alpha-agonists, 
since neither mitochondria nor microsomes possess catecholamine 
receptors (El-Refai et al. 1979). It has been shown that the 
incubation of rat hepatocytes with the glycogenolytic hormones
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angiotensin, vasopressin and epinephrine, stimulates the 
breakdown of phosphatidyl inositol and its labelling with P 
during resynthesis (Billah and Michel 1 , 1979), and similar
responses have been observed in association with alpha-1 
adrenergic stimulation in various other tissues (Michel 1, 1975). 
It has been postulated, therefore, that a phospholipid mechanism 
couples the stimulation of alpha-1 receptors to calcium- 
mobilising receptors, and that the binding of alpha-agonists to 
receptors on the cell surface results in the breakdown of 
phosphatidyl inositol to phospholipid "second messengers" which in 
turn mediate calcium mobilisation (Michel 1 , 197 5). The
stimulation of insect salivary glands with 5-hydroxytryptamine 
has been shown to result in the rapid h y d r o l y s i s  of 
phosphatidyl inositol 4,5-biphosphate, with the subsequent 
intracellular accumulation of 1,2-diacy1glycero1 and myoinositol
1,4,5 triphosphate (Berridge, 19 83). The latter compound has, in 
turn, been shown to stimulate the selective release of calcium 
ions from a non-mitochondria 1 store in rat pancreatic acinar 
cells (Streb et al. 1983) and hepatocytes (Joseph et al. 1984), 
as well as in a variety of other cell types (Joseph, 1984).
It is currently believed that the key substrate in the 
activation of alpha-1 receptors is phosphatidyl inositol 4,5 
biphosphate which is hydrolysed to the two "second messengers", 
myoinositol 1,4,5 triphosphate and diacylglycerol (Berridge 1984; 
Nishizuka, 1984; Bell, 1986), the former having an effect on 
calcium ion mobilisation, and the latter being involved in the 
activation of the enzyme protein kinase C, which together with
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calcium ions appears to be responsible for the Induction of 
typical alpha-1 adrenergic effects (Nishizuka, 1984; Bell, 1986). 
The demonstration, however, that vasopressin-stimulated 
hydrolysis of phosphatidylInositol 4,5-biphosphate in hepatocytes 
is calcium dependent, and requires a far greater dose of agonist 
than is necessary for either an increase in phosphorylase 
activity or calcium mobilisation has raised some doubts about the 
hypothesis (Rhodes et a 1 . 1983). The role of inositol 1,4,5
triphosphate in the mobilisation of calcium ions has, moreover, 
recently been questioned (Kunos, 1984).
(iii) The role of cyclic guanosine triphosphate regulatory 
proteins: These compounds may also be involved in alpha-1
adrenergic responses (Cockcroft and Gomperts, 1985; Litosch et 
al. 1985; Homey and Graham, 1985) although their precise role is 
stil 1 poorly understood. It has been suggested that the receptor- 
mediated turnover of inositol 4,5 biphosphate may be coupled 
through GTP-dependent activation of the enzyme phospholipase C 
(Bell, 1986).
5.2.2 The Mediation of Smooth Muscle Contraction by 
Alpha-1 Adrenergic Receptors 
The smooth muscle from most tissues except the intestine 
contracts in response to alpha-1 adrenergic stimulation, and it 
is generally accepted that a rise in intracellular calcium ion 
levels is involved (Bolton, 1979). It is likely that subsequently 
a calcium-calmodulin complex activates myosin light chain kinase 
with phosphorylation of tne light chain of myosin, thereby
53
. IW
i,
I k
allowing th® interaction of this protein with actin and 
permitting smooth muscle contraction (Adel stein and Hathaway, 
1979) (see Chapter 5.1.2).
'■nr .
5.2.3 Activation of Alpha-2 Adrenergic Receptors
While presynaptic alpha-2 receptors are known to mediate the 
inhibition of norepinephrine release from adrenergic nerve 
endings, the molecular mechanisms involved in their function 
remain uncertain (Exton, 1982? Homey and Graham, 1985).
Postsynaptic alpha-2 receptors are involved in a number of 
tissue reactions, including platelet aggregation and the 
inhibition of insulin secretion. They appear to share with 
muscarinic receptors the property of lowering intracellular 
levels of 3,5 cyclic AMP by inhibiting adenyl cyclase (Jakobs ®t 
al. 1984), and have been identified by radioligand binding, and 
shown to be associated with this property in a variety of tissues 
(Exton, 19 82) . In a situation analagoua to the bata- 
adrenergically mediated stimulation of adenyl cyclase, the alpha- 
2 mediated inhibition of the enzyme has been clearly shown to be 
guanine nucleotide dependent in both human platelets (Steer and 
Wood, 1979) and rat islets of Langerhans (Katada and Ui, 1981). 
Furthermore, the alpha-2 receptors of rabbit platelets exhibit 
either a high or a low affinity state for epinephrine, that of 
high affinity being converted into one of low affinity by guanine
nucleotides (Michel et al. 1980).
The activating effect of GTP on the epinephrine-induced 
inhibition of adenyl cyclase in rat islets has been shown to be
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reduced by the addition of "islet activating protein", a toxin 
from B. pertussis (Katada and Ui, 1981). This toxin catalyses the 
ADP-ribosylation of a 41,000 Dalton nembrane-bound protein which 
appears to be one subunit of a protein with 41,000 Dalton and 
35,000 Dalton subunits which can be purified from rabbit liver 
(Katada et a 1 . 1984? Bokoch et al. 19 84). The protein is capable 
of regulating adenyl cyclase activity in human platelets. It 
appears to be identical with the inhibitory guanine nucleotide 
regulatory protein (G-protein) which couples alpha-2 agonist 
receptor binding with guanosine triphosphate-associated adenyl 
cyclase inhibition (Katada et al. 1984). It has been suggested 
that the stimulation of alpha-2 receptors results in a 
dissociation of the beta- and a 1pha-subunits, and that as the 
concentration of the inhibitory G-protein is considerably in 
excess of its stimulatory analogue, the 35,000 Dalton beta- 
subunit binds to the alpha-subunit of the stimulatory protein, 
thereby preventing it from activating adenyl cyclase (Gilman,
1984) (see Chapter 5.1.1). The precise molecular mechanisms 
involved have not, however, been defined with certainty.
5.3 MUSCARINIC RECEPTORS
Although it has recently been suggested (Venter, 1983) that 
muscarinic receptors lack major structural and phylogenetic 
diversity, they appear to display heterogeneity in the affinity 
of their binding to the antagonist ligand pirenzepine on the 
basis of which they have been classified into Ml- and M2-
' • ><
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subtypes. The former occur in sympathetic ganglia, and the latter 
in peripheral effector organs such as the heart (Hammer and
Giachetti, 1982).
5.3.1 Muscarinic Receptor Activation
The binding o f  agonists to muscarinic receptors appears to 
stimulate two major biochemical responses which are identical to 
those associated with alpha-1 and alpha-2 receptor stimulation 
respectively, namely (i) an increase in the cytosolic free 
calcium ion concentration, probably mediated by a phospholipid 
coupling mechanism; (ii) the inhibition of adenyl cyclase with a 
fall in the intracellular level of 3,5 cyclic AMP.
(i) The role of calcium ions:
While the effects of agonist binding to muscarinic receptors 
have been known for some time to be mediated by a rise in the 
cytosolic free calcium ion concentration in a variety of tissues 
(Rasmussen and Goodman, 1977), doubts have existed until 
relatively recently about the c o u p l i n g  of these two events. As in 
the case of alpha-1 adrenergic receptors, it is possible that 
phospholipid compounds may act as "second messengers".
Hokin and Hokin reported in 1954 that muscarinic agonists 
stimulated an enhanced turnover of phospholipids in pancreatic 
tissue, both in vitro and in vivo, and that this was associated 
with an increased incorporation of P32. An increased turnover of 
inositol lipids has subsequently been demonstrated to be 
associated with cholinergic activity in a variety of tissues 
(Michel 1 , 1975), and it has been proposed, therefore, that, as
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in the case of alpha-1 adrenergic receptors, phosphoinositide 
breakdown i, a necessary antecedent to calcium ion mobilisation. 
This postulate has been supported by the finding that carbachol 
accelerates the synthesis and accumulation of phosphatidate in 
frog smooth muscle cells. The time course of the effect is 
similar to that of muscle contraction, which can also be 
stimulated directly by the phosphatidate itself (Salmon and
Honeyman, 1980).
A number of studies have suggested that phosphatidyllnositol
4,5 biphosphate is the key substrate in this mechanism, as well
a. in alpha-1 adrenergic responses and Intracellular levels of 
the compound have been shown to decline in rat parotid acinar 
cells (Weiss et al. 198”) and pancreas (Putney et al. 1983) xn 
response to muscarinic stimulation, the effects being rapid and 
independent of calcium ions (Weiss et al. 1982; Putney et al. 
1983). in addition, whereas both carbachol and myoinositol 1,4,5 
triphosphate stimulate the release of calcium from intracellular 
stores, prior treatment of the cell, with the lattxr compound 
appears to abolish the response to the former. This clearly 
suggests that both agents are acting on the same pool of 
releasable calcium, and that myoinositol 1,4,5 triphosphate is 
the mediator of the response to carbachol (Str.b et al. 1983). It 
appears, therefore, that, a. with alpha-1 receptor activation, 
the key substrate is phosphatidyllnositol 4,5 blpho.phat. which 
is h , - » o l y . . d  to myoinositol 1,4,5 triphosphate and 
diacylglycerol (Berridge, D84; Nishizuka, 1984; Bell, 1986), the 
former having an effect on calcium ion mobilisation and the
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latter being involved in the activation of protein kinase C 
which, together with calcium ions, is responsible for the 
induction of typical muscarinic effects (Nishizuka, 1984; Bell, 
1986). In both canine and bovine tracheal smooth muscle, the link 
between the stimulation of muscarinic receptors, the hydrolysis 
of phosphatidyl inositol 4,5 biphosphate and calcium ion 
mobilisation has recently been co- (Hashimoto et al. 1985;
Grandordy et al. 1986).
Recent work has suggested that GTP regulatory proteins may
also be involved in these responses (Cockroft and Gomperts, 1985; 
Litosch et al. 1985; Bell, 1986).
(ii) Inhibition of Menyl Cyclases
In 1962 Murad et al. demonstrated that cholinergic agonists
diminished the level of 3,5 cyclic AMP in canine m y o d a l
homogenates, and it is now known that the stimula -,n of 
muscarinic - as well as alpha-2 adrenergic - agonists results in 
the inhibition of adenyl cyclase (Jakobs et al. 1984). It has 
been suggested (see Chapter 5.2.3) that the beta and gamma 
subunits of the inhibitory guanine nucleotide regulatory protein 
dissociate from the alpha-subunit in response to muscarinic - as 
well as alpha-2 adrenergic - receptor stimulation, and that as 
the inhibitory guanine nucleotide regulatory protein exists in a 
greater concentration than its stimulatory analogue, a 
reassociation may occur between the beta-subunit of the 
inhibitory protein and the alpha-subunit of the stimulatory 
protein preventing the latter from activating adenyl cyclase 
(Gilman, 1984). An alternative mechanism that has been suggested
is that the a 1pha-subunit of the inhibitory regulatory protein 
directly inhibits adenyl cyclase in association with GTP
(Hi1debrandt et al. 1985).
A number of important questions relating to muscarinic
receptor function remain unanswered. The question of the relative
importance of the two major biochemical responses to muscarinic
stimulation in different tissues requires clarification. It has
recently been suggested that either one or the other of these
occurs in different experimental cell lines (Harden et al. 1986).
Studies of muscarinic receptors in embryonic chick heart cells,
however, have suggested that both responses are present, and that
the receptors associated with them can be differentiated on the
basis of the affinity of their binding to different muscarinic
agonist, (Brown and Brown, 1984). In addition, the Importance of
the functional differentiation of muscarinic receptors into the
Ml- a n d  M 2 - s u b t y p e s  o n  t h e  b a s i s  o f  t h e  a f f i n i t y  o f  t h e i r  b i n d i n g
to the antagonist ligand pirenzepine is uncertain. It has
recently bean suggested that the smooth muscle and epithelial
receptors of the bovine airway are predominantly of the M2- (low
pirenzepine affinity) subtype (Madison et al. 1985; Grandordy et
al. 1986).
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CHAPTER 6
urmCTIONAL CHANGES IN AUTONOMIC RECEPTORS
A number of endogenous and exogenous factors may produce 
changes in the function of autonomic receptors. Because beta- 
adrenergic receptors are linked to the relatively well defined 
biological effector system involving adenyl cyclase, much of 
current knowledge regarding autonomic receptor regulation is 
based on studies involving them. Accordingly, virtually all the 
data reviewed in the present section is concerned with functional 
changes in beta-adrenergic receptors.
6.1 AGONIST-INDUCED RECEPTOR DESENSITISATION
Although it is well known that the stimulation of receptor- 
by agonists in any tissue results, after a variable period, in a 
diminished level of responsiveness, the mechanisms underlying 
the phenomenon have only recently begun to be elucidated.
Kakiuchi and Rail reported in 1968 that, whereas, the 
incubation of rabbit cerebellum with norepinephrine resulted in 
an initial large increase in the tissue content of 3,5 cyclic 
adenosine monophosphate (3,5 cyclic AMP), this was followed by 
the progressive disappearance of the nucleotide. Prolonged 
exposure was associated, moreover, with a reduced 3,5 cyclic AMP 
response on the subsequent readdition of agonist. Later studies 
confirmed that this desensitisation process occurred following 
exposure to different adrenergic agonists in a variety of cell 
types (de Vellis and Brooker, 1974; Franklin et al. .^975;
Browning et al. 1976).
The mechanism of this desensitisation remained uncertain. It
was suggested that it was related to the release from cel Is of an 
inhibitory substance (Ho and Sutherland, 1971; Fain and Shepherd,
1975), and the desensitising effect was shown to be attenuated by 
inhibitors of RNA and protein synthesis (de Vellis and Brooker, 
1974; Browning et al. 1976). Studies attempting to relate the 
d.Bensitlsation process to the induction of phosphodiesterase 
yielded conflicting results (de Vellis and Brooker, 1974;
Browning et al. 1976).
It appeared, moreover, that the process of desensitisation
could remain limited to the agonist - or class of agonists - by 
which it had been induced or could, once established, involve 
differer . classes of agonists as well. Thus, while both 
catecholamines and prostaglandin Et could induce a diminished 3,5 
cyclic AMP response in cultured cells, desensitisation induced by 
incubation with either of these types of agonists for less than 
30 minutes remained specific for the inducing agonist. Incubation 
for a longer period with either agonist, however, desensitised 
the cell, not only to the original inducing agonist, but to the 
other as well (Su et al. 1976). The latter form of non-specific 
desensitisation was designated "heterologous" and hormone- 
specific desensitisation was designated "homologous" (Su et al
1976). It was further observed that the incubation of the cells 
with dibutryl cyclic AMP, an analogue of 3,5 cyclic AMP induced 
diminished responsiveness to both n o r e p i nephrine and 
prostaglandin E v  with a time course and extent similar to that 
associated with heterologous desensitisation, suggesting that the 
latter process was in some way mediated by the same mechanism
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which activates adenyl cyclase. (Pu et al. 1976). In a later 
study it was shown that whereas isoproterenol induced a markedly 
decreased 3,5 cyclic AMP response to catecholamines together with 
some diminution in beta-receptor numbers, prostaglandin B p  while 
also inducing a diminished response to catecholamines, had no 
effect on the number of beta-receptors. It was concluded that 
agonist-specific or "homologous" desensitisation might be 
related to a reduction in the number of beta-receptors as well as 
to the cyclic AMP-mediated phenomenon observed in association 
with non-specific or "heterologous" desensitisation (Johnson et
al. 1978).
6.1.1 "Downregulation" and "Uncoupling" of Receptors
It is now evident that a diminution or "downregulation" in 
the number of beta-receptors is associated with catecholamine- 
specific desensitisation in a wide variety of cell types. A 
marked reduction in catecholamine-stimulated adenyl cyclase 
activity occurs in the erythrocytes of frogs treated for 24 hours 
with isoproterenol and is associated with a decrease in the 
number of beta-adrenergic receptors (Mukherjee et al. 1976). 
Similar changes occur following the incubation of frog 
erythrocytes with catecholamines in vitro (Mickey et al. 1976). 
It has also been shown that short periods of therapy with beta- 
adrenergic agonists are associated with a marked diminution m  
the density of beta-receptors as wall as the 3,5 cyclic AMP 
responses of human leukocytes (Conolly and Greenacre, 1976? 
Gal ant et al. 1978? Scarpace et al. 1982).
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